Why Vericel Stock Is Soaring Today
Shares of Vericel (NASDAQ: VCEL), a healthcare company focused on sports medicine and severe burn care, were up 11% as of 3:08 p.m. EST in the wake of strong third-quarter results.
The key numbers from Varicel's third quarter looked great:
The strong Q3 results allowed management to raise its full-year guidance. Revenue is now expected to land between $116 million and $118 million. That's above its previous guidance range of $112 million to $116 million, and also comfortably ahead of the $115.3 million that Wall Street was expecting.
Source Fool.com